Further, our analysis shows that MEN1, DAXX or ATRX and PTEN mutations commonly co-occur, suggesting that combined loss of those tumor suppressors is likely a key event in pancreatic neuroendocrine cell tumorigenesis. The gene discussed is MEN1; the disease is neoplasm.